Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
<h4>Background</h4>Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profi...
Main Authors: | Akash Malhotra, Ryan Thompson, Margaretha De Vos, Anura David, Samuel Schumacher, Hojoon Sohn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0290496 |
Similar Items
-
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
by: Akash Malhotra, et al.
Published: (2023-01-01) -
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
by: Akash Malhotra, et al.
Published: (2024-01-01) -
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Published: (2024-01-01) -
Utility of CB-NAAT in cutaneous tuberculosis: A prospective observational study
by: Parul Verma, et al.
Published: (2025-03-01) -
Creative Aspects of Hafeez Taib’s Naat
by: Dr. Shagufta Firdous Dr. Muhammad Afzal Butt
Published: (2022-12-01)